Pathway Browser

Visualize and interact with Reactome biological pathways

Analysis Tools

Merges pathway identifier mapping,
over-representation, and expression analysis


Designed to find pathways and network patterns related to cancer and other types of diseases


Information to browse the database and use its principal tools for data analysis

Reactome Research Spotlight

With current treatments, focal segmental glomerulosclerosis (FSGS), the largest cause of nephrotic syndrome, frequently progresses to end stage kidney disease. Gebeshuber et al. in the September 2023 issue of Translational Research assembled 376 FSGS-associated proteins into a FSGS pathophysiology model, major components of which were Reactome pathways for Signal transduction and Hemostasis. The 39 proteins shared between FSGS model and a 102-protein model for the antiplatelet drug clopidogrel included 20 therapeutic targets of the drug. Tested in a FSGS mouse model, clopidogrel significantly attenuated disease severity, repositioning the drug as an attractive candidate for human clinical trials for FSGS.


Why Reactome

Reactome is a free, open-source, curated and peer-reviewed pathway database. Our goal is to provide intuitive bioinformatics tools for the visualization, interpretation and analysis of pathway knowledge to support basic research, genome analysis, modeling, systems biology and education. 

European Bioinformatics Institute (EMBL-EBI)
NYU Langone Health
Oregon Health & Science University
Ontario Institute for Cancer Research

The development of Reactome is supported by grants from the US National Institutes of Health (U24 HG012198) and the European Molecular Biology Laboratory.

Version 86 released on September 13th, 2023


Human Pathways






Small Molecules




Literature References

Cite Us!